Sodium Iodide → 6-(Benzyloxy)-2-[2-(4-cyclobutylpiperazin-1-yl)-2-oxoethyl]-1,2,3,4-tetrahydroisoquinoline
반응식
[CH2:1]([O:8][C:9]1[CH:10]=[C:11]2[C:16](=[CH:17][CH:18]=1)[CH2:15][NH:14][CH2:13][CH2:12]2)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.Cl[CH:20]1[CH2:25][N:24]([CH:26]2[CH2:29][CH2:28][CH2:27]2)[CH2:23][CH2:22][NH:21]1.[C:30](N)(=[O:32])[CH3:31].C([O-])([O-])=O.[K+].[K+].[Na+].[I-]>C(#N)C.O>[CH2:1]([O:8][C:9]1[CH:10]=[C:11]2[C:16](=[CH:17][CH:18]=1)[CH2:15][N:14]([CH2:31][C:30]([N:21]1[CH2:22][CH2:23][N:24]([CH:26]3[CH2:29][CH2:28][CH2:27]3)[CH2:25][CH2:20]1)=[O:32])[CH2:13][CH2:12]2)[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1참가 물질
반응물 4
생성물 1
시약·촉매·용매 2
실험 절차
To a stirred solution of 6-benzyloxy-1,2,3,4-tetrahydroisoquinoline (1.5 g, 6.26 mmol) in acetonitrile (20.0 ml) is added 2-chloro-(4-cyclobutyl-piperazine)-acetamide (1.36 g, 6.26 mmol, 1.0 eq.), K2CO3 (1.73 g, 12.5 mmol, 2.0 eq.), and NaI (180 mg). The resulting mixture is stirred at rt overnight. Water (20.0 ml) is added to quench the reaction, and then the acetonitrile is evaporated. The residue is extracted with DCM (20 ml×3). The combined organic phase is dried over sodium sulfate, and the solvent is removed under reduced pressure to give a residue that is purified by PTLC (EtOAc/4% TEA) to give the title compound. 1H NMR (300 MHz, CDCl3) δ 7.30-7.44 (5H, m), 6.84-6.94 (1H, m), 6.70-6.80 (2H, 1 m), 5.20 (2H, s), 3.60-3.74 (6H, m), 3.56 (2H, s), 2.62-2.92 (5H, m), 2.22-2.32 (4H, m), 1.60˜2.10 (6H, m); MS (+VE) m/z 420.2 (M++1).
후처리
- customto quench
- customthe reaction
- customthe acetonitrile is evaporated
- extractionThe residue is extracted with DCM (20 ml×3)
- dry with materialThe combined organic phase is dried over sodium sulfate
- customthe solvent is removed under reduced pressure
- customto give a residue that
- customis purified by PTLC (EtOAc/4% TEA)
출처 및 근거
- ORD 기록
- ord-5851f3d8a14a448b84a0ca5c825ece0a
- 출처 데이터셋
- uspto-grants-2010_09
- 특허 번호
- US07795262B2
반응 노트
불러오는 중…